Business Of Biotech

221 Folgen

1. Biotech Cash Management with Allan Shaw

   Vom: 7.8.2023
2. Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.

   Vom: 31.7.2023
3. Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard

   Vom: 24.7.2023
4. COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD

   Vom: 17.7.2023
5. ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.

   Vom: 10.7.2023
6. Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD

   Vom: 3.7.2023
7. Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah

   Vom: 26.6.2023
8. Population-Level Health Impact With Vaxxinity's John Krayacich

   Vom: 19.6.2023
9. The Face Of African Biotech with Adrienne Leussa, Ph.D.

   Vom: 12.6.2023
10. The Innovation Reduction Act with Allan Shaw

    Vom: 5.6.2023
11. Propagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.

    Vom: 29.5.2023
12. Resilient Biopharma Leadership With Ambrx's Dan O'Connor

    Vom: 22.5.2023
13. Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman

    Vom: 15.5.2023
14. A More NIIMBL Biotech Workforce With John Balchunas

    Vom: 8.5.2023
15. Building Flagship Pioneering With Avak Kahvejian, Ph.D.

    Vom: 1.5.2023
16. Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.

    Vom: 24.4.2023
17. Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren

    Vom: 17.4.2023
18. Functional Ectopic Organs with LyGenesis' Michael Hufford, Ph.D.

    Vom: 10.4.2023
19. Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.

    Vom: 3.4.2023
20. Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.

    Vom: 27.3.2023